Acquirer | Target | Price |
---|---|---|
Novartis AG | Selexys Pharmaceuticals Corp. | $665 million |
Allergan plc | Chase Pharmaceuticals | $125 million |
Magellan Health, Inc. | Veridicus Holdings, LLC | $74.5 million |
Sun Pharma | JSC Biosintez | $60 million |
QuintilesIMS | TKL Research's clinical trials division | N/A |